LINC01799

Across TCGA pan-cancer cohorts, LINC01799 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01799 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC01799 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01799 expression acts as an unfavorable survival marker, although some lineages such as ACC and CHOL show a favorable association.

THCA, LUSC, and LGG are the cancer types where LINC01799 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	III,IV	0.790	0.985	<.001	81	view →
LUSC	OS	Tertile	IV	0.057	0.786	.008	38	view →
LGG	OS	Tertile	All	0.645	0.840	<.001	36	view →
LIHC	DFS	Tertile	III,IV	0.145	0.361	.013	30	view →
ACC	DFS	Tertile	IV	0.633	0.069	.017	22	view →
CHOL	DFS	Tertile	III,IV	0.779	0.152	.013	18	view →
KIRP	OS	Tertile	All	0.896	0.962	.008	16	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.845	.009	14	view →
SARC	DFS	Quartile	All	0.632	0.468	.010	14	view →
CESC	DFS	Tertile	III,IV	1.000	0.569	.038	12	view →
TGCT	DFS	Tertile	II,III,IV	0.678	0.996	.015	12	view →
DLBC	OS	Tertile	All	0.200	0.906	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01799–THCA (OS)

Open the THCA breakdown →